Non-secreting myeloma with myelomatous kidney. a case of parciall resistance to melphalen and cyclophosphamide with favorable response to nitrosourea combination
Peña Yáñez, A.; Bermúdez, J.M.; Raya, J.; Salmerón, J.; Palomo, S.
Revista Clinica Espanola 143(6): 543-550
1976
ISSN/ISBN: 0014-2565 PMID: 796906 Document Number: 109646
Document emailed within 1 workday
Related Documents
Uzuka, Y.; Saito, Y.; Takahashi, H.; Komatsu, M.; Ito, T. 1989: Combination chemotherapy of multiple myeloma--BCNU.cyclophosphamide.procarbazine.prednisolone and MCNU.cyclophosphamide.procarbazine.prednisolone therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 16(6): 2269-2273Bonfanti, S.; Avanzi, C. 1991: A case of IgM-secreting myeloma Minerva Medica 82(9): 599-601
Bernardeschi, P.; Bonechi, I. 1988: Non-secreting anaplastic myeloma. Description of a primary case Recenti Progressi in Medicina 79(1): 30-31
Zeller, W.J.; Berger, M.R.; Henne, T.; Weber, E. 1986: More than additive toxicity of the combination of 1-methyl-1-nitrosourea plus 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat Cancer Research 46(4 Part 1): 1714-1716
Fernández González, M.J.; Matía Cubillo, A.C.; González Sanz, R.; Juárez Redondo, I.; Jimeno Carrúez, A. 2001: Multiple myeloma lambda IgG: myelomatous pleural effusion, an unusual presentation Anales de Medicina Interna 18(3): 161-162
Ricci, C.; Coscia, G.C.; Uberti, M.; Discalzi, G.; Racca, P. 1982: Reclassification of multiple myeloma and calculation of the myelomatous mass as prognostic and therapeutic indications Recenti Progressi in Medicina 72(4): 482-499
Kamaeva, O.I.; Kostiagina, N.M.; Pimenova, N.S.; Shestakova, I.N. 1995: A case of a combination of sarcoidosis and myeloma Terapevticheskii Arkhiv 67(12): 57-59
Neretto, G.; Giovanelli, E.; Bianco, G.; Caligaris, F. 1978: Non-secreting myeloma Minerva Medica 69(19): 1309-1314
Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Sugimoto, K.; Sakamoto, K.; Amemiya, K.; Tsuchiya, Y.; Hagiwara, T.; Matsuzawa, H.; Makino, Y.; Motegi, S.; Kawai, M.; Ishiyama, S.; Kamiyama, H.; Takahashi, M.; Kojima, Y.; Tomiki, Y.; Kuwatsuru, R. 2019: A Case of Good Quality of Life(QOL)and Favorable Response to Transarterial Chemoembolization(TACE)against Synchronous Multiple Liver Metastases Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(4): 730-732
Andreeva, N.E.; Litvinenko, A.I.; Iakovleva, S.V.; Sokolova, O.M. 1992: A myeloma secreting immunoglobulin M (a report of 2 cases) Terapevticheskii Arkhiv 64(10): 39-42
Tashiro, K.; Kondo, N.; Ikemoto, I. 1986: A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil Hinyokika Kiyo. Acta Urologica Japonica 32(3): 449-453
Inoue, T.; Okada, H.; Shioda, K.; Takahira, S.; Kanno, Y.; Sugahara, S.; Nakamoto, H.; Suzuki, H. 2001: A case of myeloma kidney complicated by extramedullary plasmacytoma with massive bleeding Nihon Jinzo Gakkai Shi 43(4): 347-350
Chauffert, B.; Bonnotte, B.; Chvetzoff, G.; Flesch, M. 1998: The major response of metastatic kidney cancer to the combination of oxaliplatin, 5-fluorouracil and folinic acid (FOX-FOL) Presse Medicale 27(18): 859
Nowak, C.; Arnold, W.; Henneberger, G.; Tanneberger, S. 1980: Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems Archiv für Geschwulstforschung 50(8): 747-757
Koike, K.; Fukami, K.; Morishige, S.; Hazama, T.; Taguchi, K.; Ando, R.; Nagano, M.; Yoshimura, J.; Ueda, S.; Hashiguchi, M.; Tamaki, K.; Nishida, H.; Okuda, S. 2009: Case of acute kidney injury related to intravenous zoledronic acid in a patient with multiple myeloma Nihon Jinzo Gakkai Shi 51(5): 557-562
Eton, O.; Scheinberg, D.A.; Houghton, A.N. 1989: Establishment and characterization of two human myeloma cell lines secreting kappa light chains Leukemia 3(10): 729-735
Qi, Y.; Moyana, T.; Chen, Y.; Xiang, J. 1996: Characterization of anti-tumor immunity derived from the inoculation of myeloma cells secreting the fusion protein RM4/IFN-tau Human Antibodies and Hybridomas 7(1): 21-26
Palumbo, A.; Boccadoro, M.; Bruno, B.; Triolo, S.; Pileri, A. 1994: Cyclophosphamide (3.6 g/m2) therapy with G-CSF support for resistant myeloma Haematologica 79(6): 513-518
Iannitto, E.; Scaglione, R.; Musso, M.; Abbadessa, V.; Licata, G. 1988: Intrapleural adriamycin in treatment of myelomatous pleural effusion: a case report Haematologica 73(4): 325-326